Document Detail

Synthetic delivery systems for intravenous administration of nucleic acids.
MedLine Citation:
PMID:  17716119     Owner:  NLM     Status:  MEDLINE    
At present, there are no intravenously administered nucleic acid-based therapeutics that have been approved for human use. This reflects the difficulties in applying nucleic acid-based drugs: they are nuclease sensitive and have difficulties in reaching their site of action. Important challenges for intravenously administered nucleic acid formulations are the requirements that they can transport the nucleic acids efficiently in the circulation, have the ability to direct nucleic acids to the desired cell type and are able to steer their intracellular processing. Here, we evaluate nanotechnological strategies that improve the pharmacokinetics and colloidal stability of nucleic acids in the bloodstream, focus biodistribution towards the target tissue and facilitate interactions with and trafficking within the desired cell type.
Raymond M Schiffelers; Holger K de Wolf; Inge van Rooy; Gert Storm
Related Documents :
22840939 - Status of cis and trans fatty acids in brazilian adolescent mothers and their newborns.
16386949 - The sensitive determination of nucleic acids using resonance light scattering quenching...
12216739 - The acidity of uracil and uracil analogs in the gas phase: four surprisingly acidic sit...
9806459 - Simple and broadly applicable sample preparation by use of magnetic glass particles.
8013949 - Nucleic acid amplification and infectious disease.
610229 - Effect of tetracycline on the formation of nucleic acid bases formed in photochemically...
7733039 - Plasma cholesterol-predictive equations demonstrate that stearic acid is neutral and mo...
8246839 - Regulation of fatty acid biosynthesis in escherichia coli.
6658889 - Difference between cholic acid and chenodeoxycholic acid in dependence upon cholesterol...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Nanomedicine (London, England)     Volume:  2     ISSN:  1748-6963     ISO Abbreviation:  Nanomedicine (Lond)     Publication Date:  2007 Apr 
Date Detail:
Created Date:  2007-08-24     Completed Date:  2007-09-18     Revised Date:  2010-01-28    
Medline Journal Info:
Nlm Unique ID:  101278111     Medline TA:  Nanomedicine (Lond)     Country:  England    
Other Details:
Languages:  eng     Pagination:  169-81     Citation Subset:  IM    
Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, PO Box 80082, 3508 TB Utrecht, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Drug Carriers / chemistry*
Gene Targeting / methods*
Gene Therapy / methods*
Injections, Intravenous / methods*
Nanomedicine / methods
Nanostructures / chemistry*
Nucleic Acids / administration & dosage*,  chemistry*
Reg. No./Substance:
0/Drug Carriers; 0/Nucleic Acids

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Targeted delivery of multifunctional magnetic nanoparticles.
Next Document:  Oral administration of peptides and proteins: nanoparticles and cyclodextrins as biocompatible deliv...